IBEX Limited
NASDAQ:IBEXInformation Technology Services
-$0.52 today
- Market cap
- $743.63M
- Beta
- 0.70
- P/E (TTM)
- 8.5
- EPS (TTM)
- $3.51
Volume 0.20M
Average 0.12M
IBEX Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
IBEX LimitedNASDAQ: IBEX
Depreciation & Amortization · Q3 FY2026 · quarter ended Mar 2026
Depreciation & amortization growth accelerates
Q3 FY2026 depreciation & amortization of $5.17M rose 19.4% year over year, ahead of the +5.4% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 8.8% from the prior quarter. Over 3 fiscal years it compounded at -1.6% a year.
Context
- Depreciation & amortization amounted to 3.1% of revenue in FY2025, down 0.7 pp from a year earlier.
- Depreciation & amortization increased in 2 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +19.4% holds above the trailing-twelve-month pace of +5.4%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 17.23M USD
- Year-over-year change
- -11.5%
- 4-year CAGR
- +5.1%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | 17.23M | -11.5% |
| FY2024 | 2024-06-30 | 19.46M | +2.5% |
| FY2023 | 2023-06-30 | 18.99M | +4.9% |
| FY2022 | 2022-06-30 | 18.1M | +28.2% |
| FY2021 | 2021-06-30 | 14.12M | — |
Depreciation & Amortization vs competitors
How IBEX compares with its peers on the latest reported figures
- IBEX's LTM Mar 2026 depreciation & amortization of $18.55M is the lowest of the 4 companies compared; the peer median is $193M.
- Its year-over-year change of +5.4% is the highest of 4, against a peer median of -3.8%.
- Depreciation & amortization amounts to 3.0% of revenue for IBEX, versus a peer median of 6.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Feb 2026 | $656.38M | -3.8% | +28.1% | 6.6% | |
| LTM Mar 2026 | $193M | +1.6% | -5.5% | 6.4% | |
| LTM Mar 2026 | $88.37M | -7.5% | -7.1% | 4.2% | |
| LTM Mar 2026 | $18.55M | +5.4% | -1.6% | 3.0% | |
| Peer median (excluding IBEX) | $193M | -3.8% | -5.5% | 6.4% | |
Competitors are the stored peer set for IBEX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Revenue | 443.39M | 492.85M | 523.12M | 508.57M | 558.27M |
| Cost of Revenue | 335.25M | 373.97M | 374.99M | 356.54M | 385.69M |
| Gross Profit | 108.14M | 118.88M | 148.13M | 152.03M | 172.58M |
| Gross Margin | 24.4% | 24.1% | 28.3% | 29.9% | 30.9% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 0 | 80.15M | 88.66M | 93.14M | 108.74M |
| Operating Expenses | 91.09M | 98.25M | 107.65M | 112.6M | 125.97M |
| Depreciation & Amortization | 14.12M | 18.1M | 18.99M | 19.46M | 17.23M |
| EBITDA | 38.31M | 38.77M | 60.1M | 60.96M | 64.8M |
| EBITDA Margin | 8.6% | 7.9% | 11.5% | 12.0% | 11.6% |
| Operating Income | 17.05M | 20.63M | 40.48M | 39.43M | 46.61M |
| Operating Margin | 3.8% | 4.2% | 7.7% | 7.8% | 8.3% |
| Interest Income | 0 | 43K | 640K | 2.07M | 955K |
| Interest Expense | 9.03M | 1.29M | 792K | 514K | 1.63M |
| Other Income / Expenses | (1.89M) | (1.25M) | (152K) | 1.56M | (679K) |
| Income Before Tax | 15.15M | 19.38M | 40.33M | 40.99M | 45.93M |
| Pre-Tax Margin | 3.4% | 3.9% | 7.7% | 8.1% | 8.2% |
| Income Tax Expense | 2.06M | (2.08M) | 8.74M | 7.33M | 9.07M |
| Net Income | 13.09M | 21.46M | 31.58M | 33.66M | 36.86M |
| Net Margin | 3.0% | 4.4% | 6.0% | 6.6% | 6.6% |
| EPS (Basic) | 0.16 | 1.18 | 1.74 | 1.90 | 2.51 |
| EPS (Diluted) | 0.15 | 1.15 | 1.67 | 1.84 | 2.36 |
| Weighted Avg Shares | 17.65M | 18.23M | 18.2M | 17.7M | 14.68M |
| Weighted Avg Shares (Diluted) | 18.38M | 18.72M | 18.89M | 18.26M | 15.73M |
IBEX Limited
NASDAQ:IBEX
Intrinsic Alpha fair value
Locked
Current Price
$55.77
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.